Abstract
Li et al. find that fructose-1,6-bisphosphatase 1 (FBP1) levels are uniformly reduced in clear cell renal cell carcinoma (ccRCC), identifying a new mechanism of metabolic reprogramming in this cancer type.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have